μ‐Opioid receptor‐stimulated synthesis of reactive oxygen species is mediated via phospholipase D2
Authors:
Open Access
- 21 July 2009
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 110 (4) , 1288-1296
Abstract
We have recently shown that the activation of the rat μ‐opioid receptor (MOPr, also termed MOR1) by the μ‐agonist [d‐Ala2, Me Phe4, Glyol5]enkephalin (DAMGO) leads to an increase in phospholipase D2 (PLD2) activity and an induction of receptor endocytosis, whereas the agonist morphine which does not induce opioid receptor endocytosis fails to activate PLD2. We report here that MOPr‐mediated activation of PLD2 stimulates production of reactive oxygen molecules via NADH/NADPH oxidase. Oxidative stress was measured with the fluorescent probe dichlorodihydrofluorescein diacetate and the role of PLD2 was assessed by the PLD inhibitor d‐erythro‐sphingosine (sphinganine) and by PLD2‐small interfering RNA transfection. To determine whether NADH/NADPH oxidase contributes to opioid‐induced production of reactive oxygen species, μ‐agonist‐stimulated cells were pre‐treated with the flavoprotein inhibitor, diphenylene iodonium, or the specific NADPH oxidase inhibitor, apocynin. Our results demonstrate that receptor‐internalizing agonists (like DAMGO, β‐endorphin, methadone, piritramide, fentanyl, sufentanil, and etonitazene) strongly induce NADH/NADPH‐mediated ROS synthesis via PLD‐dependent signaling pathways, whereas agonists that do not induce MOPr endocytosis and PLD2 activation (like morphine, buprenorphine, hydromorphone, and oxycodone) failed to activate ROS synthesis in transfected human embryonic kidney 293 cells. These findings indicate that the agonist‐selective PLD2 activation plays a key role in the regulation of NADH/NADPH‐mediated ROS formation by opioids.Keywords
This publication has 58 references indexed in Scilit:
- Morphine Enhances Microglial Migration through Modulation of P2X4Receptor SignalingJournal of Neuroscience, 2009
- Redox Regulation of Cell SurvivalAntioxidants & Redox Signaling, 2008
- Myocyte Enhancer Factor 2C as a Neurogenic and Antiapoptotic Transcription Factor in Murine Embryonic Stem CellsJournal of Neuroscience, 2008
- Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor κB transcriptional activation in neuroblastoma SH-SY5Y cellsBiochemical Journal, 2007
- Phospholipase D2 Localizes to the Plasma Membrane and Regulates Angiotensin II Receptor EndocytosisMolecular Biology of the Cell, 2004
- ADP-ribosylation Factor-dependent Phospholipase D Activation by the M3 Muscarinic ReceptorJournal of Biological Chemistry, 2003
- Activation of phospholipase D by metabotropic glutamate receptor agonists in rat cerebrocortical synaptosomesBritish Journal of Pharmacology, 2000
- Type Iα phosphatidylinositol 4‐phosphate 5‐kinase is a putative target for increased intracellular phosphatidic acidFEBS Letters, 2000
- Endothelin receptors stimulate both phospholipase C and phospholipase D activities in different cell linesEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Phosphatidic acid and not diacylglycerol generated by phospholipase D is functionally linked to the activation of the NADPH oxidase by FMLP in human neutrophilsBiochemical and Biophysical Research Communications, 1990